A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Mg0004 50077, New York

Mg0004 50096, Philadelphia

Mg0004 50088, Washington D.C.

Mg0004 50090, Winston-Salem

Mg0004 50120, Miami

Mg0004 50073, Tampa

Mg0004 50121, Lexington

Mg0004 50114, Indianapolis

Mg0004 50072, Los Angeles

Mg0004 50081, Phoenix

Mg0004 50066, Montreal

Mg0004 50070, Québec

Mg0004 50069, Toronto

Mg0004 40125, Ostrava-Poruba

Mg0004 40124, Prague

Mg0004 40128, Aalborg

Mg0004 40129, Bordeaux

Mg0004 40132, Nice

Mg0004 40133, Paris

Mg0004 40131, Strasbourg

Mg0004 40140, Göttingen

Mg0004 40078, Leipzig

Mg0004 40177, Münster

Mg0004 40144, Milan

Mg0004 40146, Pavia

Mg0004 40148, Roma

Mg0004 40150, Roma

Mg0004 20078, Hanamaki Shi

Mg0004 20079, Hiroshima

Mg0004 20077, Miyagi

Mg0004 20076, Shinjuku-Ku

Mg0004 20032, Suita

Mg0004 40155, Gdansk

Mg0004 40154, Lodz

Mg0004 40151, Lublin

Mg0004 20027, Moscow

Mg0004 20001, Saint Petersburg

Mg0004 20028, Saint Petersburg

Mg0004 20055, Saint Petersburg

Mg0004 40159, Barcelona

Mg0004 40157, L'Hospitalet de Llobregat

Mg0004 20080, Taichung

Mg0004 20081, Taipei